Expert brief: Several common symptoms of kidney cancer

Clinically, the symptoms of early kidney cancer are almost the same as other kidney diseases, so it is often easily misdiagnosed as other kidney diseases, and the best time for treatment is missed, which is not good for kidney cancer patients. So what are the common symptoms of kidney cancer ? Here are some common symptoms of kidney cancer.

Common symptoms of kidney cancer include:

1. Abdominal mass: About 20% of kidney cancer patients have abdominal mass, which is more likely to occur in patients with slender bodies. It is located under the ribs in the upper abdomen and can move up and down with breathing. It is a common symptom of kidney cancer. The examiner may touch the tumor itself or the lower pole of the kidney that has been moved by the tumor. If the mass is fixed, it means that the tumor has invaded the organ structure around the kidney. It is difficult to remove the tumor in such patients, and the prognosis is poor.

2. Hematuria: The kidneys are connected to the outside world through urine, so hematuria is one of the common symptoms of kidney cancer. It is caused by tumors invading the renal pelvis or calyx mucosa. About 40-60% of patients will have different degrees of hematuria, which is usually intermittent and painless to the naked eye. Sometimes there are strips of blood clots, which are ureteral casts. When blood clots block the ureter, it can cause renal colic.

3. Pain: The pain caused by kidney cancer mostly occurs in the waist, and is dull in nature, with an incidence rate of about 20%. In addition to the tumor growth stretching the renal capsule, it can also be caused by the tumor invading surrounding organs or psoas muscles. The latter pain is often heavier and lasting. This is a common symptom of kidney cancer.

The above are the common symptoms of kidney cancer, I hope it will be helpful to everyone. Once the symptoms of kidney cancer appear, you must go to the hospital for treatment immediately so that you can receive better treatment and control the deterioration of the disease in time, which is beneficial for kidney cancer patients.